Crinetics Pharma DEF 14A: Executive Compensation Details
Ticker: CRNX · Form: DEF 14A · Filed: Apr 23, 2025 · CIK: 1658247
| Field | Detail |
|---|---|
| Company | Crinetics Pharmaceuticals, Inc. (CRNX) |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
Related Tickers: CRNX
TL;DR
CRNX DEF 14A out - exec comp details for 2020-2024, focus on equity awards.
AI Summary
Crinetics Pharmaceuticals, Inc. filed a DEF 14A on April 23, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, including equity awards granted and vested for the years 2020 through 2024. Specific figures for the change in fair value of outstanding equity awards are provided for the 2021, 2022, and 2024 fiscal years.
Why It Matters
This filing provides transparency into how Crinetics Pharmaceuticals compensates its top executives, which can influence investor perception and company strategy.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing detailing executive compensation and does not present new material risks.
Key Numbers
- 2020-2024 — Fiscal Years Covered (Executive compensation data spans these years.)
Key Players & Entities
- Crinetics Pharmaceuticals, Inc. (company) — Filer
- 0000950170-25-057452 (filing_id) — Accession Number
- 20250423 (date) — Filing Date
- 20250611 (date) — Period of Report
- 1231 (date) — Fiscal Year End
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing is a proxy statement filed by companies to solicit shareholder votes and provide information on matters such as executive compensation, director elections, and other corporate governance issues.
What specific compensation details are highlighted in this filing for Crinetics Pharmaceuticals?
This filing highlights details regarding executive compensation, specifically focusing on equity awards granted and vested, and the change in fair value of these awards for various fiscal years.
Which fiscal years are covered by the compensation data in this DEF 14A filing?
The compensation data presented in this filing covers the fiscal years 2020, 2021, 2022, 2023, and 2024.
What is the company's standard industrial classification?
Crinetics Pharmaceuticals, Inc. is classified under 'PHARMACEUTICAL PREPARATIONS [2834]'.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 23, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 regarding Crinetics Pharmaceuticals, Inc. (CRNX).